<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression SignaturesJason H. Mendler, Clara D. Bloomfield, Krzysztof Mrózek et al.|Journal of Clinical Oncology|2012Cited by 268
Evolution of acute myelogenous leukemia stem cell properties after treatment and progressionTzu‐Chieh Ho, Michael W. Becker, Mark W. LaMere et al.|Blood|2016Cited by 236
Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene ScoreGuido Marcucci, Clara D. Bloomfield, Pearlly S. Yan et al.|Journal of Clinical Oncology|2013Cited by 157
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaChristian Niederwieser, C. D. Bloomfield, Jessica Kohlschmidt et al.|Leukemia|2014Cited by 77
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn‐Kathrin Eisfeld, Clara D. Bloomfield, Guido Marcucci et al.|Blood|2012Cited by 69